pembrolizumab in msi-h crc tumors
Published 7 years ago • 2.1K plays • Length 9:02Download video MP4
Download video MP3
Similar videos
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
1:28
dr. bekaii-saab on the response rate of pembrolizumab in msi-h crc
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
4:56
asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer
-
6:27
immunotherapy in msi-high pancreatic tumors
-
35:42
immunotherapy in crc | 2023 best of gi cancer conference
-
9:25
debate: msi high colon cancer - immunotherapy
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
2:03
pembrolizumab therapy for microsatellite instability-high colorectal cancer
-
5:20
pembrolizumab improves on chemo in msi-h/dmmr mcrc
-
0:54
dr. bendell discusses pembrolizumab in crc
-
6:56
keynote-177 results: pembrolizumab versus chemotherapy for patients with msi-h/dmmr colorectal c...
-
0:54
dr. diaz on response rates with pembrolizumab for crc
-
0:50
zev wainberg, md, on the role of pembrolizumab for msi high crc patients and its use in therapy
-
3:29
lenvatinib and pembrolizumab in microsatellite stable crc
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
1:16
findings for pembrolizumab plus mfolfox6 in advanced crc
-
1:15
dr. diaz on pembrolizumab for crc
-
2:11
pembrolizumab vs. chemo in first-line mcrc